PTEN and malignant glioma: Other results derived from the analysis of EGFR/EGFRvIII and PTEN in recurrent malignant gliomas from patients who received EGFR kinase inhibitors revealed that co-expression of EGFRvIII and PTEN was associated with responsiveness [130].